By Counterforce Health Team in Bavencio (avelumab) —

Getting Bavencio (Avelumab) Covered by Blue Cross Blue Shield in Washington: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Bavencio Covered by Blue Cross Blue Shield in Washington

Bavencio (avelumab) requires prior authorization from Blue Cross Blue Shield plans in Washington for FDA-approved uses—metastatic Merkel cell carcinoma and maintenance urothelial carcinoma. Submit PA requests via provider portal or fax with diagnosis codes, staging, prior platinum therapy history, and NCCN guidelines. If denied, you have 180 days to appeal internally, then can request external review through Washington's Office of the Insurance Commissioner. Start today: Call the number on your insurance card to verify PA requirements and gather clinical documentation.

Table of Contents

  1. What Drives Bavencio Coverage Costs
  2. Investigating Your Blue Cross Blue Shield Benefits
  3. Manufacturer Assistance and Copay Programs
  4. Prior Authorization Process and Requirements
  5. Common Denial Reasons and How to Fix Them
  6. Appeals Process in Washington
  7. Specialty Pharmacy vs. Medical Benefit Considerations
  8. Annual Renewal and Budget Planning
  9. Conversation Scripts for Success
  10. FAQ

What Drives Bavencio Coverage Costs

Bavencio (avelumab) is a specialty oncology medication that typically falls under your medical benefit rather than your pharmacy formulary. This means it's covered like other infused treatments at your oncology clinic, not like pills you'd pick up at a pharmacy.

Key cost factors include:

  • Tier placement: Most Blue Cross Blue Shield plans place Bavencio on high-cost tiers (often $1,000+ category)
  • Medical benefit structure: Usually 20-30% coinsurance after deductible
  • Site of care: Outpatient infusion centers typically cost less than hospital settings
  • Prior authorization requirements: Nearly universal across BCBS plans

The manufacturer's wholesale cost varies by negotiated rates, but patient responsibility depends on your specific plan's benefit design.

Investigating Your Blue Cross Blue Shield Benefits

Before starting treatment, gather this essential information by calling the member services number on your insurance card:

Questions to Ask:

  1. "Is prior authorization required for Bavencio (avelumab) under my plan?"
  2. "What's my coinsurance percentage for specialty infusions?"
  3. "Which infusion sites are in-network for oncology treatments?"
  4. "What's my out-of-pocket maximum for medical benefits this year?"
  5. "Do you have a preferred specialty pharmacy for coordination?"

Information to Record:

  • PA reference number or code
  • Preferred provider portal (Availity, BlueApprovR)
  • Medical director contact for peer-to-peer reviews
  • Appeals department fax and mailing address
Tip: Ask specifically about "medical benefit" coverage, not pharmacy formulary. Many representatives need this clarification for infused medications.

Manufacturer Assistance and Copay Programs

EMD Serono (Merck KGaA) and Pfizer offer the CoverOne program for eligible patients:

CoverOne Copay Assistance:

  • Up to $30,000 annual support for commercially insured patients
  • Can reduce copays to as little as $0
  • Excludes: Medicare, Medicaid, and other government programs
  • Enrollment: Call 844-826-8371 or visit bavencio.com/CoverOne

CoverOne Patient Assistance (Free Drug):

  • For uninsured/underinsured patients meeting income criteria (typically ≤400-500% Federal Poverty Level)
  • Required documents: Tax returns, pay stubs, bank statements
  • Includes case management and nursing support

Application process: Enroll before treatment starts. Your oncology team can help coordinate enrollment and benefits verification.

Prior Authorization Process and Requirements

Step-by-Step PA Submission

1. Verify Requirements (Day 1)

  • Call Blue Cross member services to confirm PA needed
  • Ask for specific forms or portal access
  • Timeline: 5-10 minutes

2. Gather Clinical Documentation (Days 1-3)

  • Patient information and insurance ID
  • Diagnosis with ICD-10 codes:
    • Merkel cell carcinoma: C44.10-C44.19
    • Urothelial carcinoma: C67.9
  • Staging and imaging reports
  • Prior treatment history (especially platinum-based chemotherapy for urothelial carcinoma)
  • ECOG performance status (typically 0-2 required)

3. Submit PA Request (Day 3-5)

  • Online: Provider portal (Availity for most BCBS plans)
  • Fax: Varies by plan (verify current number)
  • Phone: Medical director line for urgent cases
  • Timeline: Standard 5-14 business days; expedited 72 hours

Coverage at a Glance

Requirement What It Means Where to Find It
Prior Authorization Required for all FDA indications BCBS medical policies
FDA Indication Match Metastatic MCC or maintenance UC FDA label
Performance Status ECOG 0-2 typically required Oncologist assessment
Prior Therapy Documentation Platinum failure for UC patients Treatment records
Site of Care In-network outpatient preferred Provider directory

Common Denial Reasons and How to Fix Them

Denial Reason How to Overturn Required Documents
"Not FDA-approved indication" Submit exact diagnosis match Pathology report, staging
"Missing prior therapy documentation" Provide complete treatment history Chemotherapy records, dates
"Inadequate performance status" Update ECOG assessment Recent clinic note
"Non-preferred site of care" Request exception or change location Cost comparison, access justification
"Experimental/investigational" Cite FDA approval date FDA approval letter

Medical Necessity Letter Checklist

When appealing or submitting PA, ensure your oncologist includes:

  • Problem statement: Specific cancer type and stage
  • Prior treatments: What was tried and why it failed or caused intolerance
  • Clinical rationale: Why Bavencio is appropriate now
  • Guideline support: NCCN guidelines reference
  • Monitoring plan: How response will be assessed

Appeals Process in Washington

Washington state provides strong consumer protections through a structured appeals process:

Internal Appeals (Levels 1-2)

Level 1 Appeal:

  • Deadline: 180 days from denial notice
  • Decision timeline: 30 days standard, 72 hours expedited
  • Submit to: Plan-specific address (check denial letter)
  • Required: Signed member authorization, medical records, denial letter

For Premera Blue Cross:

  • Mail: Premera Blue Cross, ATTN: Member Appeals, PO Box 91102, Seattle, WA 98111-9202
  • Fax: (425) 918-5592

For Regence BlueShield:

Level 2 Appeal:

  • Deadline: 30 days from Level 1 denial
  • Process: New reviewer examines case
  • Success rate: 70-78% for well-documented cases

External Review (Independent Review Organization)

If internal appeals fail, Washington offers free external review:

  • Deadline: 4 months (120 days) from final internal denial
  • Process: Independent medical experts review case
  • Contact: Washington Office of the Insurance Commissioner
  • Timeline: ~45 days for decision
  • Binding: If approved, insurer must provide coverage
Note: External review decisions favoring patients are binding on the insurer. Washington's IRO process has helped many patients access specialty cancer medications.

Specialty Pharmacy vs. Medical Benefit Considerations

Medical Benefit Coverage (Most Common):

  • Bavencio administered at oncology clinics
  • Covered under medical benefits (not pharmacy)
  • Coinsurance typically 20-30% after deductible
  • No quantity limits like traditional prescriptions

Coordination Tips:

  • Verify in-network infusion sites before treatment
  • Ask about 90-day authorization to reduce administrative burden
  • Coordinate with CoverOne program for maximum savings
  • Consider outpatient hospital vs. physician office costs

Pharmacy Benefit (Rare):

  • Some plans may cover under specialty pharmacy
  • Higher cost-sharing possible
  • May require specialty pharmacy delivery

Annual Renewal and Budget Planning

Plan for Annual Changes:

  • October-November: Review plan formularies for next year
  • December: Enroll in new plans if needed during open enrollment
  • January: Renew prior authorizations and copay assistance programs
  • Quarterly: Track progress toward out-of-pocket maximum

Budget Considerations:

  • Out-of-pocket maximum: Typically $8,000-$9,000 for individual coverage
  • Deductible: Often $2,000-$5,000 before coinsurance begins
  • CoverOne assistance: Up to $30,000 annually can significantly reduce costs

Conversation Scripts for Success

Script 1: Calling Blue Cross Member Services

"Hi, I need to verify coverage for Bavencio, spelled B-A-V-E-N-C-I-O, for metastatic Merkel cell carcinoma. Can you tell me if prior authorization is required and what my coinsurance percentage would be under medical benefits?"

Script 2: Requesting Peer-to-Peer Review

"I'm calling to request a peer-to-peer review for a Bavencio prior authorization denial. The patient has metastatic Merkel cell carcinoma, which is an FDA-approved indication. Can you schedule time for our oncologist to speak with your medical director?"

Script 3: Appealing to Washington OIC

"I'm calling about an external review request for a specialty cancer medication denial. My Blue Cross plan denied coverage after internal appeals, and I'd like to request an Independent Review Organization evaluation."

Counterforce Health specializes in helping patients and clinicians navigate complex prior authorization and appeals processes for specialty medications like Bavencio. Our platform analyzes denial letters and creates targeted, evidence-backed appeals that align with payer-specific requirements, improving approval rates and reducing administrative burden for oncology practices.

FAQ

Q: How long does Blue Cross PA take for Bavencio in Washington? A: Standard prior authorization decisions take 5-14 business days. Expedited requests (when delay could harm health) are decided within 72 hours.

Q: What if Bavencio isn't on my Blue Cross formulary? A: Since Bavencio is typically covered under medical benefits rather than pharmacy formulary, formulary status may not apply. Request a medical necessity review instead.

Q: Can I get expedited appeals in Washington? A: Yes, if your health could be seriously harmed by delays. Both internal appeals (72 hours) and external reviews offer expedited timelines.

Q: Does the CoverOne program work with all Blue Cross plans? A: CoverOne works with commercial Blue Cross plans but excludes government programs like Medicare and Medicaid. Verify eligibility at 844-826-8371.

Q: What happens if I miss appeal deadlines? A: Washington allows 180 days for internal appeals and 120 days for external review. If you miss deadlines, contact the OIC for guidance—exceptions may apply in certain circumstances.

Q: Can my doctor request emergency coverage? A: Yes, physicians can request expedited prior authorization or emergency coverage when treatment delays could cause serious harm. This typically requires clinical documentation of urgency.

Sources & Further Reading

Disclaimer: This guide provides general information about insurance coverage and appeals processes. It is not medical advice or a guarantee of coverage. Always consult with your healthcare provider about treatment decisions and verify current policies with your specific insurance plan. For personalized assistance with appeals, consider consulting with Counterforce Health or other specialized advocacy services.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.